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To reduce the health care burden of strokes, the Taiwan Department of Health launched the Pilot Scheme of the Health Policy in
Stroke Adjuvant Acupuncture Therapy (HPSAAT) in 2006. This cross-sectional, hospital-based, match-controlled study at Chang
Gung Memorial Hospital-Kaohsiung Medical Center during 2006∼2008 retrospectively evaluated the clinical characteristics of
acute and subacute ischemic stroke patients who electively joined the HPSAAT. The study also evaluated the safety and clinical
beneﬁts of adjuvant acupuncture in treating acute and subacute ischemic stroke patients. Twenty-six HPSAAT participants and 52
age-sex matched random controls were enrolled. The stroke baseline of the HPSAAT participants was more severe than the non-
HPSAAT controls. Although the stroke severity closely correlates to mortality and comorbidity, this study noted no signiﬁcant
complications in the HPSAAT participants during the acupuncture treatment course. Adjuvant acupuncture was considered safe
at the acute and subacute stages of ischemic stroke. Due to uneven baseline severity, the clinical beneﬁts in reducing neurological
deﬁcits and functional recovery were not concluded in this study.
1.Introduction
As one of the leading causes of death, strokes contribute
to a worldwide health care burden [1, 2]. Acupuncture has
long been applied in treating stroke patients and has thus
been recommended by the World Health Organization [3].
The National Health Insurance (NHI) is the social insurance
that has covered the medical expenses of over 99% of 23.0
million Taiwanese citizens since 1995 [4–6]. In Taiwan,
acupuncture prevailed in one ﬁfth of NHI beneﬁciaries [7].
Aiming to improve the health care of stroke patients, the
Department of Health launched an NHI-sponsored national
project in 2006, namely the Pilot Scheme of the Health
Policy in Stroke Adjuvant Acupuncture Therapy (HPSAAT).
The HPSAAT promotes integration of traditional Chinese
medicine (TCM) in conventional stroke care. In 2010, the
HPSAAThasbeenconductingin27medicalcentersandlocal
hospitals under an annual budget of 2.7 million US dollars.2 Evidence-Based Complementary and Alternative Medicine
Patients with newly onset stroke (during the past year)
receive support and elective acupuncture. Both inpatient
treatment and outpatient clinic visits are covered.
Along the clinical course of ischemic stroke, the most
important period of recovery is at the acute and subacute
stage [8]. In this study, we sought to identify the characteris-
ticsofacuteandsubacutestrokepatientswhoelectivelychose
to participate in the HPSAAT. We also aimed to evaluate the
safety of adjuvant acupuncture in stroke inpatient care.
Among patients with stroke, the major cause of death is
from medical complications [9] that mostly develop within
the ﬁrst 6 weeks after stroke onset [10]. The incident rate of
medical complications increases with the baseline severity of
stroke. A higher score of the National Institution of Health
Stroke Scale (NIHSS) [11, 12] or a higher dependency at
stroke onset [10] is correlated to an increase of medical
complications. Among all medical complications during
acute and subacute stroke, infection is the most common
medical complication [13] and is an independent predictor
of mortality and poor functional outcome [9, 14, 15]. The
high prevalence of poststroke infections, as well as other
postCNS(centralnervoussystem)injuryinfections,hasbeen
supposed to be the consequence of CNS immunodepression
with imbalanced subsets of helper T cells [16, 17]. In
acupuncture theory, correcting imbalances is the ultimate
goal of needling. Both proinﬂammatory and inﬂammatory
eﬀects have been observed in acupuncture studies [18].
The postacupuncture sequential change of peripheral blood
leukocyte subpopulation and cytokines reveals immune-
boosting eﬀects [19, 20]. Based on the previous ﬁndings, we
hypothesize that acupuncture has the potential to correct
CNS injury-induced immunodepression and reduce the
infectious complications of stroke patients. In this study, we
attempted to use age-sex matched control to evaluate the
clinicalbeneﬁtsofadjuvantacupunctureinreducingmedical
complications in HPSAAT participants.
The other major burden in stroke care involves neu-
rological deﬁcits and functional impairment. The acute
and subacute stages account for the golden time of stroke
recovery [8]. The plasticity of the brain signiﬁcantly
aﬀects stroke recovery [21]. In recent systematic reviews of
acupuncture in acute ischemic stroke, potential therapeutic
eﬀects have been noticed [22, 23]. Acupuncture increases
regional cerebral blood ﬂow in the hypoperfusion area
surrounding the ischemic core and in the sensorimotor
area of the aﬀected and unaﬀected hemisphere of the brain
in ischemic stroke patients [24]. A functional MRI study
conﬁrmed that acupuncture elicits higher signals in the
somatosensory area of poststroke brains [25]. In this study,
we compared the neurological improvement between the
HPSAAT participants and age-sex matched controls.
2.Method
2.1. Study Design and Patients. This research involved
a cross-sectional, hospital-based, matched-control study
conducted at Chang Gung Memorial Hospital-Kaohsiung
Medical Center (KCGMH). The study was approved by the
institutional review board of KCGMH. Acute and subacute
stroke patients admitted to the neurology ward and neurol-
ogy intensive care unit (NICU) from 1 July 2006 to 30 June
2008 were assessed for eligibility. Ischemic stroke is deﬁned
by ICD-9 code 434. Only admissions for initial management
of acute and subacute ischemic stroke were included. Re-
admissions of a single patient during the investigation
period were excluded. Among ischemic stroke patients,
some patients electively joined the HPSAAT to receive
adjuvant acupuncture. Occasionally, families of patients
with cognitive impairment made the decision regarding
HPSAAT participation. After patients began participating in
the HPSAAT, TCM doctors received a consultation sheet,
visited the HPSAAT participants, and began the treatment
course.
Inthis study, HPSAAT participants were allocated to case
groups. Matched control group members were randomly
selected among the nonHPSAAT participants by 1:2 age-
sex matching [26]. Those cases whose medical records did
not present suﬃcient neurological descriptions for NIHSS
scoring were excluded. The enrolled cases were retrieved for
fullchartreviewoftheadmission courseand6-monthperiod
of poststroke followup at KCGMH (Figure 1).
2.2. Procedures. All patients received concomitant stroke
care in the neurology ward and/or in NICU. In addition,
experienced TCM doctors visited the HPSAAT participants
three times per week and performed acupuncture treatment.
The acupuncture point selection was determined by doctor
clinical evaluation in accordance with TCM principles. After
manual acupuncture, the disposable stainless needles were
retained for 15 minutes. When clinical conditions deteri-
orated or infectious conditions occurred, doctors of both
neurologyand TCMcouldevaluatethepatientsand decideif
acupuncture should be administered.
2.3. Data Collection. The demographicproﬁlesrecordedage,
sex, and body mass index. The clinical proﬁle regarding
strokes recorded stroke types, lesion sites, previous strokes,
and risk factors. The population proﬁle recorded patient
sources, dispositions, and timescale of treatment. The med-
ical resource proﬁle recorded thrombolytic therapy (r-tPA),
NICU stay, craniectomy or shunt implantation, mechanical
ventilation,bedsidephysicaltherapy,andlengthofstay.Con-
founding factors of outcome were assessed by a baseline
NIHSS [27] and a baseline modiﬁed Rankin Scale (mRS)
[28]. We retrospectively scored the NIHSS [29, 30]a n d
mRS by an independent clinical investigator certiﬁed by the
American Heart Association professional education center
[31].
Neurological complications were recorded as recurrent
stroke during admission and stroke-in-evolution [32]. Med-
ical complications during admission were evaluated by
urinary tract infection, pneumonia, and cellulitis [13]. Also
thestresseventsrepresentedbygastrointestinal (GI)bleeding
episodes, hemodynamic stability evaluated by vital sign
at 09:00 a.m. of the day next to admission day and of
the day before discharge day. Signiﬁcant adverse events ofEvidence-Based Complementary and Alternative Medicine 3
27 HPSAAT§ participants
1 excluded for
insuﬃcient
record of
neurological
examination
Case group: 26 eligible patients
Record demographic and clinical proﬁles
Retrospectively scored NIHSS∗∗ and
mRS† on admission, at consult, and at
discharge
Record 6-month-followup at KCGMH‡
Control group: 52 eligible patients
Record demographic and clinical
proﬁles
Retrospectively scored NIHSS∗∗ and
mRS† on admission and at discharge
Record 6-month-followup at KCGMH‡
Statistical analyses
Patients who had died or had recurrent stroke during admission was
excluded from outcome analysis
4064 acute ischemic stroke patients (ICD-9 code 434) admitted to
neurology ward and NICU∗ during 1st Jul 2006 to 30th Jun 2008
divided by adjuvant acupuncture or none
4036 nonparticipants
Randomized to a 1:2 age-sex matching
Figure 1: Participant ﬂowsheet. ∗NICU, neurology intensive care unit. ∗∗NIHSS, National Institutes of Health Stroke Scale. Scored by one
independent physician with certiﬁcation of American Heart Association Professional Education Center website. †mRS, modiﬁed Rankin
Scale. ‡KCGMH, the ChangGung MemorialHospital-KaohsiungMedical Center. §HPSAAT, the PilotScheme ofthe Health Policyin Stroke
Adjuvant Acupuncture Therapy. HPSAAT provides stroke patients elective acupuncture at outpatients and inpatients departments during
the ﬁrst year after stroke onset.
acupuncture were reviewed [33]. We also traced patient
admission records and outpatient visits at KCGMH for a
6-month period. Patients who had died or had a recurrent
stroke during admission were separated from outcome
analysis.
2.4. Statistical Analysis. Categorical data were expressed by
frequency (percentage) and were examined by a chi-squared
test. Continuous data were expressed by mean (standard
deviation)and were examined byan independent t-test. A P-
value < .05 in a 2-tailed test was considered to be statistically
signiﬁcant. Data were analyzed using a commercial software
program, SPSS version 17.0 for Windows; SPSS Inc.
3.Results
This study involved 273 HPSAAT participants, most of
them were in the stroke recovery stage and admitted
in rehabilitation wards. Only 27 participants with acute
and subacute ischemic stroke were eligible for the case
group. One case was further excluded due to insuﬃcient
neurological examination records for retrospective NIHSS
scoring, leaving 26 participants in the case group. Fifty-
two age-sex matched controls were randomly selected from
4,036 acute and subacute ischemic stroke patients who did
not participate in the HPSAAT but received conventional
treatment indiscriminately (Figure 1).
The characteristic proﬁle of the HPSAAT participants
and age-sex matched nonHPSAAT controls showed no dif-
ference in demographics, stroke type (Table 1(a)), or patient
source (Table 1(b)). However, the HPSAAT participants
seemed to have longer treatment courses, including length
of stay in NICU, in the neurology ward, and in total
(32.9 ± 21.9:13.8 ± 16.1d a y s ,P<. 001). Compared to
the nonHPSAAT controls, the HPSAAT participants tended
to stay in health care institutions after discharge from the
neurology ward and/or NICU, including the rehabilitation
ward, TCM ward, and long-term care units (Table 1(b)).
Bedside physical therapy was more prevalently applied to the
HPSAAT participants (92.3%:53.8%, P = .001; Table 1(c)).
The HPSAAT participants in the neurology ward and
NICUstarted adjuvantacupunctureanaverageof17.7±14.4
days after stroke onset and continued the treatment course
for 17.4 ± 16.2d a y sw i t h6 .7 ± 6.4 acupuncture sessions
(Table 1(b)). The safety of acupuncture was evaluated in a4 Evidence-Based Complementary and Alternative Medicine
Table 1: Clinical characteristics.
HPSAAT participants
(n = 26)
Matched control:non
HPSAAT (n = 52) P-value
(a) Demographics
Age, years∗ 70.2 (11.3) 70.2 (11.1) Matched
Sex, male∗∗ 16 (61.5) 32 (61.5) Matched
Body mass index, kg/m2∗ 23.5 (3.2) 23.8 (3.6)
Stroke ever∗∗ 14 (53.8) 26 (50.0)
Stroke type∗∗
Ischemic 23 (88.5) 50 (96.2)
Ischemic with hemorrhagic
transformation 3 (11.1) 2 (3.7)
Stroke lesion site∗∗
Right cerebral hemisphere 5 (19.2) 16 (30.8)
Left cerebral hemisphere 8 (30.8) 15 (28.8)
Cerebellum 0 (0.0) 2 (3.8)
Brain stem 5 (19.2) 11 (21.2)
Multiple infarcts (≥2 of above) 8 (30.8) 8 (15.4)
Risk factors of stroke∗∗
Hypertension 20 (76.9) 33 (63.5)
Diabetes mellitus 14 (53.8) 25 (48.1)
Hypertriglyceridemia 7 (26.9) 10 (19.2)
Hypercholesterolemia 11 (42.3) 17 (32.7)
Atrial ﬁbrillation 5 (19.2) 6 (11.5)
Coronary artery disease 5 (19.2) 4 (7.7)
Congestive heart failure 0 (0.0) 1 (1.9)
Cigarette smoking 6 (23.1) 16 (30.8)
Obesity 7 (31.8) 14 (33.3)
(b) Patients’ source, treatment course, and disposition
Patient source∗∗
Emergency room 20 (76.9) 39 (75.0)
Referred from other hospital 3 (11.5) 4 (7.7)
Outpatients 1 (3.8) 9 (17.3)
Referred from other ward in
hospital 2 (7.7) 0 (0.0)
Timescale of treatment, days∗
Onset to ward 2.9 (4.7) 2.3 (3.1)
Onset to acupuncture 17.7 (14.4) —
Duration of acupuncture† 17.4 (16.2) —
Acupuncture session, times 6.7 (6.4) —
Interval of acupuncture sessions 2.9 (1.5) —
Length of stay, days∗,‡
In NICU 11.6 (14.1) 2.2 (4.7) <.01
In neurology ward 19.2 (8.6) 11.6 (12.7) <.01
In RCC 2.0 (5.5) 0.0 (0.0)
Total 32.9 (21.9) 13.8 (16.1) <.001
Disposition∗∗,‡
Home 16 (64.0) 46 (95.8) .001
Rehabilitation ward 4 (16.0) 0 (0.0) <.05
Traditional Chinese medicine ward 1 (4.0) 0 (0.0)
Long-term care unit§ 5 (20.0) 2 (4.2) <.05Evidence-Based Complementary and Alternative Medicine 5
Table 1: Continued.
HPSAAT participants
(n = 26)
Matched control:non
HPSAAT (n = 52) P-value
(c) Medical resource use∗∗
Received r-tPA 0 (0.0) 0 (0.0)
Ever NICU stay 17 (65.4) 15 (28.8) <.01
Craniectomy or shunt implantation 2 (7.7) 0 (0.0)
Mechanical ventilation 4 (15.4) 2 (3.8)
Received bedside physical therapy 24 (92.3) 28 (53.8) .001
∗Data are given as mean (SD). ∗∗Data are given as number (percentage). †Mortality was excluded (case = 0, control = 3). ‡Mortality (case = 0, control
= 3) and patients with recurrent stroke during admission (case = 1, control = 1) were excluded. §Long-term care unit included local hospital and nursing
home. Abbreviation: HPSAAT: the Pilot Scheme of the Health Policy in Stroke Adjuvant Acupuncture Therapy. NICU: neurology intensive care unit. RCC:
respiratory care center. r-tPA: thrombolytic therapy.
detailed chart review. No vital sign instability was noted
among the HPSAAT participants during acupuncture. The
baseline vital sign on admission was not signiﬁcantly dif-
ferent between groups; whereas, the HPSAAT participants
presented lower diastolic blood pressure (76.8 ± 8.5:82.1 ±
9.7mmHg, P<. 05), lower mean arterial pressure (95.6 ±
8.9:100.7 ± 10.7mmHg, P<. 05), and faster heart rate
(79.1 ± 8.1:73.7 ± 7.2 beat per minute, P<. 01) than the
nonHPSAAT controls. The adverse event survey revealed
no needle sickness. In one participant, left-arm cellulitis
developed8daysafteracupunctureinitiation(causeundeter-
mined). An intravenous antibiotic was administered and the
acupuncture treatment was uninterrupted and completed
until the patient was discharged home. Regarding another
participant who had begun acupuncture treatment in the
neurology ward, the acupuncture treatment was interrupted
after two sessions (7 days) of treatment because of sudden
collapse and admission to NICU. The other 24 HPSAAT
participants completed the acupuncture treatment course
smoothly during the stay in the neurology ward and/or
NICU.
The mortality and comorbidity analysis began from a
baseline comparison. The baseline NIHSS was higher on
average (14.9 ± 9.4:7.5 ± 7.0, P<. 001; Table 2(a)) and was
skewed more to the left in distribution (Figure 2(a))a m o n g
the HPSAAT participants than that of the nonHPSAAT
controls. The baseline mRS of the HPSAAT participants
was also more severe than that of the nonHPSAAT controls
(dependent as mRS > 3 in 92.3%:61.5%, P<. 01), but
was distributed similarly (Figure 2(b)). Three enrolled cases
expired during admission. All mortalities occurred in the
controlgroupandwerecausedbysevereinfectionwith septic
shock. A comparison of neurological and medical compli-
cations discovered more stroke-in-evolution (34.6%:3.8%,
P = .001) and urinary tract infection (46.2%:23.1%, P<
.05) in the HPSAAT participants than in the nonHPSAAT
controls during stays in the neurology ward and/or NICU.
However, more urinary tract infections occurred before
initiating acupuncture (Table 2(b)). No diﬀerence was noted
in the occurrences of recurrent stroke, pneumonia, cellulitis,
or GI bleeding.
In the 6-month followup period, the HPSAAT partic-
ipants tended to maintain regular outpatient visits to the
rehabilitation department (20.0%:2.1%, P<. 05) and
acupuncture department (32.0%:0.0%, P<. 001). Approxi-
mately seventy percent of cases in both groups continued
following up in the neurology department for at least 6
months after stroke onset.
4.Discussion
Inthisstudy,themajorﬁnding,butalsothemajorlimitation,
was the uneven baseline severity between the HPSAAT
participants and the age-sex matched nonHPSAAT con-
trols. The acute and subacute ischemic stroke patient with
severe neurological impairment and signiﬁcantly functional
limitations was prone to joint h eH P S A A Tf o ra d j u v a n t
acupuncture in addition to conventional treatment. This
ﬁnding indicatedthe desire ofmajor ischemic stroke patients
and their families to pursue satisfying treatment modalities
or a combination of treatment modalities. This ﬁnding also
indicated thatthedevelopmentalprinciple ofacupuncturein
treating ischemic stroke should be emphasized on moderate
to severe patients.
H o w e v e r ,t h eb a s e l i n ed i s c r e p a n c yl i m i t e dt h ee ﬀective
comparison of neurological and functional outcomes. The
alternative solution may come from data mining in the
Chang Gung Stroke Registry Database, which includes clin-
ical data of all stroke patients admitted to the four branches
of Chang Gung Memorial Hospital since 2008. Searching by
the NIHSS on admission could ﬁnd the baseline equaled
populations in the database.
The varied duration of stroke onset to acupuncture
treatment (17.7±14.4days)andvaried durationofacupunc-
ture treatment (17.4 ± 16.2d a y s )a m o n gt h eH P S A A T
participants also limited the comparison of beneﬁts from
adjuvant acupuncture in ischemic stroke. For more accurate
generalization and more eﬀective comparison, a randomized
control trial is required.
Sincethe1990s,theeﬃcacyandeﬀectivenessofacupunc-
ture for acute and subacute stroke has been evaluated by
many research groups. Although some study designs have
been limited by the strength of evidence, systemic reviews
revealed the potential beneﬁts of acupuncture to patients
with acute and subacute strokes [22, 23]. The HPSAAT is
the ﬁrst public health policy-modifying project to include6 Evidence-Based Complementary and Alternative Medicine
Table 2: Mortality and comorbidity during admission and in six-month-followup.
HPSAAT participants
(n = 26)
Matched control:non
HPSAAT (n = 52) P-value
(a) Baseline comparison:factors aﬀecting mortality and comorbidity
Neurological impairment∗
Baseline NIHSS scores 14.9 (9.4) 7.5 (7.0) <.001
Interquartile range 7–22 2-11.75
NIHSS at consult 16.6 (8.8) —
NIHSS at discharge‡ 15.4 (8.3) 5.6 (5.5) <.001
Functional impairment∗∗
Baseline mRS > 3 24 (92.3) 32 (61.5) <.01
mRS > 3 at consult 25 (96.2) —
mRS > 3a td i s c h a r g e ‡ 22 (88.0) 24 (50.0) .001
(b) Mortality and comorbidity during admission∗∗
Mortality during admission 0 (0.0) 3 (5.8)
Neurological complications
Recurrent stroke 1 (3.8) 1 (1.9)
Stroke in-evolution after admission 9 (34.6) 2 (3.8) .001
Medical complications
Urinary tract infection (total) 12 (46.2) 12 (23.1) <.05
Before acupuncture 7 (26.9) —
After acupuncture 5 (19.2) —
Pneumonia (total) 9 (34.6) 11 (21.2)
Before acupuncture 9 (34.6) —
After acupuncture 0 (0.0) —
Cellulitis (total) 2 (7.7) 1 (1.9)
Before acupuncture 1 (3.8) —
After acupuncture 1 (3.8) —
Gastrointestinal bleeding 4 (15.4) 8 (15.4)
Before acupuncture 4 (15.4) —
After acupuncture 0 (0.0) —
(c) Six-month followup in KCGMH∗∗,‡
Ever readmission due to acute
disorders 2 (8.0) 7 (14.6)
Recurrent stroke within 6 months 0 (0.0) 1 (2.1)
Expire within 6 months 0 (0.0) 2 (4.2)
Outpatient followup∗∗,‡
In neurology department
First 3 months 19 (76.0) 37 (77.1)
6 months 17 (68.0) 37 (77.1)
In rehabilitation department
First 3 months 5 (20.0) 2 (4.2) <.05
6 months 5 (20.0) 1 (2.1) <.05
In acupuncture department
First 3 months 9 (36.0) 0 (0.0) <.001
6 months 8 (32.0) 0 (0.0) <.001
∗Data are given as mean (SD). ∗∗Data are given as number (percentage). †Mortality was excluded (case = 0, control = 3). ‡Mortality (case = 0, control = 3)
and patients with recurrent stroke (case = 1, control = 1) during admission were excluded. Abbreviation: HPSAAT, the Pilot Scheme of the Health Policy in
Stroke Adjuvant Acupuncture Therapy. NIHSS: National Institutes of Health Stroke Scale. mRS: modiﬁed Rankin Scale. mRS > 3 was deﬁned as dependent
status. KCGMH: the Chang Gung Memorial Hospital—Kaohsiung Medical Center.Evidence-Based Complementary and Alternative Medicine 7
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Figure2: Baselinediscrepancies between HPSAAT participants and
age-sexmatchednonparticipants.ThehistogramofbaselineNIHSS
showed the diﬀerent distribution of severity between groups.
There were more moderate to severe strokes among the HPSAAT
participants with acute and subacute ischemic stroke than the age-
sex matched nonHPSAATcontrols(a).The number and percentage
of baseline mRS showed that the HPSAAT participants were more
dependent than the random controls (b).
acupuncture in stroke care. Previous evidence has suggested
that the worse the baseline is, the worse the outcomes are.
Moderate to severe strokes had poorer outcomes [34, 35],
greater demand of long-term care [36, 37], and higher
expense of medical costs [38]. The acute and subacute
stages constitute the golden recovery period for ischemic
stroke. From this study, we found that major ischemic stroke
patients tended to choose adjuvant acupuncture in the acute
and subacute stages. Future studies must clarify whether or
nottheHPSAATreducedtheﬁnancialburden.Moreover,the
baseline severity also correlated to the increased poststroke
infections [12]. In this study, a higher rate of urinary tract
infection of the HPSAAT participants, butnot of pneumonia
or GI bleeding, was noted. The infections that occurred after
starting acupuncture treatment did not seem signiﬁcantly
increased. Therefore, in addition to improving neurological
impairment or functional recovery, acupuncture may play
a role in eliminating medical complications of stroke. The
immune-boosting potentials of acupuncture in modulating
CNS injury-induced immunodepression of acute and suba-
cute stroke is still worthy of further investigation.
The 6-monthfollowupperiod revealedfavorablecompli-
ance of the HPSAAT participants to continue acupuncture
treatment after discharge. The needs of long-term functional
recovery and the selection of acupuncture as a treatment
modality was noticed in one third of the HPSAAT partici-
pants.
5.Conclusion
This cross-sectional study analyzed data from a single
medical center to depict a brief summary of the HPSAAT
in Taiwan. Adjuvant acupuncture care is a safe modality in
the acute and subacute stages of ischemic stroke. Ischemic
stroke patients with a severe baseline tended to participate
in the HPSAAT. To validate the clinical beneﬁts of adjuvant
acupuncture care in acute and subacute ischemic stroke, a
baseline equaled randomized control trial is warranted.
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